For Immediate Release
Human Embryo Genome Editing: The Debate Continues
Contact: Kathryn Ryan
914-740-2250
kryan@liebertpub.com
New Rochelle, NY, October 27, 2020—Genome editing of human embryos is a highly controversial topic. The CRISPR Journal reports comments and reactions to the September 2020 National Academies of Sciences/UK Royal Society report on Heritable Human Genome Editing (HHGE). Click here to read the article now.
In this multi-author Perspective, The CRISPR Journal presents the views of three dozen experts from the world of genetics, CRISPR, bioethics, law, and other related areas to share their personal reactions to the HHGE report. Among the experts offering their reactions are Nobel laureate Jennifer Doudna, Art Caplan, George Church, Eric Topol, Robert Cook-Deegan, Laura Hercher, Kiran Musunuru, Hank Greely, David Liu, and Feng Zhang.
Many applaud the findings of the HHGE commission. Several constructive criticisms and recurring reservations were made, including the lack of ethical considerations, societal consensus, health disparities, and regulatory questions
“The HHGE report underscores what most researchers in this field are aware of and agree upon: There must not be any use of germline editing for clinical purposes at this time,” states Jennifer Doudna, PhD, University of California, Berkeley/HHMI.
But “HHGE might further expand the divide, where the haves receive editing for chronic illnesses or 'designer babies,' while the have-nots aren’t afforded this privilege,” cautions LaTasha Hoskins Lee, PhD, of the National Minority Quality Forum.
About the Journal
The CRISPR Journal is a groundbreaking peer-reviewed journal dedicated to outstanding research and commentary on all aspects of CRISPR and gene editing research. Published bimonthly in print and online and led by Editor-in-Chief Rodolphe Barrangou, PhD, North Carolina State University, the Journal covers CRISPR biology, technology and genome editing, and commentary and debate of key policy, regulatory, and ethical issues affecting the field. For complete information and a sample issue, please visit The CRISPR Journal website.
About the Publisher
Mary Ann Liebert, Inc., publishers is known for establishing authoritative peer-reviewed journals in many promising areas of science and biomedical research. The CRISPR Journal adds an exciting and dynamic component to the Mary Ann Liebert, Inc. portfolio, which includes GEN (Genetic Engineering & Biotechnology News) and more than 90 leading peer-reviewed journals. A complete list of the firm’s 90 journals, books, and newsmagazines is available on the Mary Ann Liebert, Inc., publishers website.